Becker's Healthcare April 4, 2025
Mounjaro (tirzepatide) led to greater weight loss and better glucose control than high doses of Trulicity (dulaglutide), according to a study published April 4 in Annals of Internal Medicine.
A common challenge for physicians prescribing GLP-1s is whether to increase the dose of Trulicity or switch patients to Mounjaro when managing uncontrolled Type 2 diabetes, according to the American College of Physicians. The 40-week study — sponsored by Eli Lilly, the manufacturer of both drugs — aimed to address this question.
Researchers compared the...
Today's Sponsors
Today's Sponsor